Actualización en plasma rico en plaquetas

The document discussed platelet-rich plasma (PRP), a blood-derived product noted for its potential anti-inflammatory effects and benefits in tissue regeneration in fields like dermatology, orthopedics, and sports medicine. As of 2019, there was no standardized protocol for PRP production or application, and the lack of robust clinical trials made it difficult to validate PRP as a routine treatment. The variability in preparation methods and treatment conditions further complicated the comparison of study results. The document emphasized the need for more rigorous research to establish standardized protocols and demonstrate PRP's effectiveness for reliable clinical use.